Craniocerebral Trauma: Clinical Trials

120 trials for Craniocerebral Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

120 completed. 120 Phase 2, 27 Phase 1, 15 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2120Completed 120
Phase 127Completed 27
Phase 315Completed 15

Follow Craniocerebral Trauma: new trials by email Literature Review of Craniocerebral Trauma trials Research Report on Craniocerebral Trauma

Trials (filtered) newest first · largest first

All 120 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCAAs in Concussion 2.0
BCAA, Placebo - Concussion, Brain, Concussion, Mild
Phase 2CompletedAkiva Cohen172025-04-012026-09-03
Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
Cannabidiol, Placebo - Brain Injuries, Traumatic
Phase 2CompletedUniversity of Colorado, Denver432023-04-112025-12-17
Sleep Management And Recovery After Traumatic Brain Injury in Kids: Pilot Intervention of Melatonin
melatonin, placebo - Traumatic Brain Injury, Critical Illness
Phase 2CompletedOregon Health and Science University212023-01-022025-08-20
Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms
Hyperbaric oxygen at 1.5 ATA, Sham treatment - Persistent Post-concussive Syndrome, Concussion Post Syndrome
Phase 2CompletedEssentia Health202022-06-282026-10-15
The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
OmniLenz® - Corneal Perforation, Exposure Keratitis
Phase 2 / Phase 3CompletedFarwaniya Hospital52022-04-102024-08-06
Cold-stored Platelet Early Intervention in TBI
Cold Stored Platelets, Standard Care - Traumatic Brain Injury
Phase 2CompletedJason Sperry1002022-03-212025-05-11
Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae
autologous bone marrow-derived mononuclear cell transplantation, Rehabilitation therapy - Sequelae of Injuries of Head
Phase 1 / Phase 2CompletedVinmec Research Institute of Stem Cell and Gene Technology502021-04-012024-10-01
Ghrelin (OXE--103) for Acute Concussion Management
Ghrelin (OXE-103), Placebo - Concussion, Brain, Traumatic Brain Injury
Phase 2CompletedMichael Rippee232020-10-202024-05-21
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-01-15
Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients
N-Acetyl cysteine - Traumatic Brain Injury
Phase 2CompletedHonorHealth Research Institute922019-09-012026-05-01
RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD)
Reconsolidation of Traumatic Memories (RTM), Prolonged Exposure (PE) - Posttraumatic Stress Disorder, Traumatic Brain Injury
Phase 2 / Phase 3CompletedUniformed Services University of the Health Sciences942019-06-122025-07-15
Evaluation the Effects of French Maritime Pine Bark Extract on the Clinical Status in Traumatic Brain Injury Patients
Dietary Supplement (OLIGOPIN), Placebo - Traumatic Brain Injury
Phase 1 / Phase 2CompletedMashhad University of Medical Sciences672019-04-142020-05-21
Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache
AMG 334 - Post-Traumatic Headache, Mild Traumatic Brain Injury
Phase 2CompletedDanish Headache Center1002019-04-052020-02-10
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study
Tranexamic Acid, Placebo - Brain Injuries, Wounds and Injuries
Phase 2CompletedDaniel Nishijima, MD, MAS312019-03-042021-09-05
Magnesium Sulphate Versus Fentanyl Sedation During Burr-hole Surgery
Magnesium Sulphate, Fentanyl, Propofol - Monitored Anesthesia Care
Phase 2CompletedKasr El Aini Hospital322019-03-012021-04-13
3MDR to Treat PTSD With mTBI (3MDR)
Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) Therapy - Posttraumatic Stress Disorder, Traumatic Brain Injury
Phase 2CompletedWalter Reed National Military Medical Center202019-01-112025-07-18
Effects of Peer Mentoring on Caregivers of Patients With Acquired Brain Injury
one-to-one peer mentoring - Acquired Brain Injury, Family Members
Phase 2CompletedShepherd Center, Atlanta GA412019-01-082021-04-20
Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury
Bromocriptine 5 MG, Acetaminophen 650 MG - Subarachnoid Hemorrhage, Subdural Hematoma
Phase 1 / Phase 2CompletedUniversity of California, San Francisco472018-11-302021-06-24
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
Temozolomide - Gastrointestinal Stromal Tumors, Sdh
Phase 2CompletedAdam Burgoyne, MD, PhD232018-09-122026-07-28
Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH
Magnesium sulphate, Fentanyl, Propofol - Conscious Sedation
Phase 2CompletedKasr El Aini Hospital342018-04-102018-12-04

Showing 20 of 120. Sign in to see all of them.

Narrower conditions

Brain Injuries, Traumatic (68)  ·  Brain Injuries (33)  ·  Brain Concussion (10)  ·  Stroke (10)  ·  Post-Concussion Syndrome (9)  ·  Post-Traumatic Headache (5)  ·  Stress Disorders, Post-Traumatic (5)  ·  Wounds and Injuries (5)  ·  Cerebral Palsy (4)  ·  Headache (4)  ·  Chronic Traumatic Encephalopathy (3)  ·  Consciousness Disorders (3)  ·  Corneal Injuries (3)  ·  Hematoma, Subdural, Chronic (3)

Broader conditions

Nervous System Diseases (120)  ·  Trauma, Nervous System (117)  ·  Wounds and Injuries (115)  ·  Brain Diseases (108)  ·  Central Nervous System Diseases (107)  ·  Brain Injuries (68)  ·  Pathological Conditions, Signs and Symptoms (47)  ·  Signs and Symptoms (32)  ·  Cardiovascular Diseases (23)  ·  Neurologic Manifestations (22)  ·  Pathologic Processes (22)  ·  Vascular Diseases (22)  ·  Cerebrovascular Disorders (21)  ·  Mental Disorders (19)

Interventions

Sodium Chloride (6)  ·  Hyperbaric Oxygenation (5)  ·  Acetylcysteine (4)  ·  Saline Solution (4)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (3)  ·  Propofol (3)  ·  Acetaminophen (2)  ·  Fentanyl (2)  ·  Magnesium Sulfate (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Melatonin (2)  ·  Methylphenidate (2)  ·  Oxyhemoglobins (2)  ·  Rosuvastatin Calcium (2)  ·  Sertraline (2)

Sponsors

University of Washington (4)  ·  National Institutes of Health Clinical Center (CC) (3)  ·  The University of Texas Health Science Center, Houston (3)  ·  University of Pennsylvania (3)  ·  Avid Radiopharmaceuticals (2)  ·  Kasr El Aini Hospital (2)  ·  Neuren Pharmaceuticals Limited (2)  ·  U.S. Army Medical Research and Development Command (2)  ·  Uniformed Services University of the Health Sciences (2)  ·  Universidad Autonoma de San Luis PotosĂ­ (2)  ·  University of British Columbia (2)  ·  University of Calgary (2)  ·  University of California, San Francisco (2)  ·  University of Magdeburg (2)  ·  University of Pittsburgh (2)

Countries

United States (77)  ·  Canada (8)  ·  United Kingdom (5)  ·  Germany (4)  ·  Denmark (3)  ·  France (3)  ·  Iran (3)  ·  Australia (2)  ·  Belgium (2)  ·  Brazil (2)  ·  China (2)  ·  Egypt (2)  ·  Israel (2)  ·  Mexico (2)  ·  New Zealand (2)

Top investigators

Charles S Cox, Jr., M.D. (2)  ·  Charles S Cox, MD (2)  ·  Eric M Wassermann, M.D. (2)  ·  Jeanne M Hoffman, PhD (2)  ·  Leighton Chan, M.D. (2)  ·  Lindell K. Weaver, MD (2)  ·  Ramon R. Diaz-Arrastia, MD, PhD (2)  ·  Ross R Bullock, M.D., PhD (2)  ·  Adam Burgoyne, MD, PhD (1)  ·  Alexander A Ostanin, MD, PhD (1)  ·  Alice Rose (1)  ·  Allen Lamb, DO (1)  ·  Allen Thornton (1)  ·  Allen W Brown, MD (1)

Results publications

PMID 31394602, PMID 31394603, PMID 41114449, PMID 15901745, PMID 17011666, PMID 17370477, PMID 18807008, PMID 19255065, PMID 19406291, PMID 19930566, PMID 20082712, PMID 22282887, PMID 22375973, PMID 22446155, PMID 22771222, PMID 22777131, PMID 23013802, PMID 23106988, PMID 23140612, PMID 23289819, PMID 23510092, PMID 23682548, PMID 23876024, PMID 23895556, PMID 24504128, PMID 24686108, PMID 24701988, PMID 24831445, PMID 24842590, PMID 25058216, PMID 25064164, PMID 25401463, PMID 25438964, PMID 26376074, PMID 26394294, PMID 26438108, PMID 26491799, PMID 26496111, PMID 26545726, PMID 26581842, PMID 27022956, PMID 27626622, PMID 27630085, PMID 28296862, PMID 28403842, PMID 28486023, PMID 28686657, PMID 28768069, PMID 28768070, PMID 28768071

NIH funding

1IK2RX001136-01A2 (1), 2009 (1), 2018 (1), K23HD049626 (1), K23HL150229 (1), K23NS048152 (1), K23NS065132 (1), P01NS038660 (1), R01HD036075 (1), R01HD070792 (1), R01NS039097 (1), R01NS052448 (1), R01NS055827 (1), R01NS061860 (1), R01NS069247 (1)